UMIN-CTR Clinical Trial

Basic information
Public title	The effect of exercise on prophylaxis and treatment with chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis
Acronym	The effect of exercise on prophylaxis and treatment with chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis
Scientific Title	The effect of exercise on prophylaxis and treatment with chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis
Scientific Title:Acronym	The effect of exercise on prophylaxis and treatment with chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis
Region	Japan

Condition
Condition	Adult cancer survivor who suffered or are at high risk of suffering chemotherapy-induced peripheral neuropathy
Classification by specialty	Hematology and clinical oncology
Classification by malignancy	Malignancy
Genomic information	NO

Objectives
Narrative objectives1	To investigate the efficacy of exercise on prophylaxis and treatment with chemotherapy-induced peripheral neuropathy
Basic objectives2	Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	The severity of peripheral neuropathy
Key secondary outcomes	The frequency of peripheral neuropathy

Base
Study type	Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	18 years-old <=
Age-upper limit	Not applicable
Gender	Male and Female
Key inclusion criteria	Adult cancer survivor who suffered or are at high risk of suffering chemotherapy-induced peripheral neuropathy
Key exclusion criteria	Patients with missing outcomes
Target sample size

Research contact person
Name of lead principal investigator	1st name Natsuki Middle name Last name Nakagawa
Organization	University of Tokyo Hospital
Division name	Respiratory Medicine
Zip code	113-8655
Address	7-3-1 Hongo, Bunkyo-ward, Tokyo, Japan
TEL	03-3815-5411
Email	nnakagawautmedsle@yahoo.co.jp

Public contact
Name of contact person	1st name Natsuki Middle name Last name Nakagawa
Organization	University of Tokyo Hospital
Division name	Respiratory Medicine
Zip code	1138655
Address	7-3-1 Hongo, Bunkyo-ward, Tokyo, Japan
TEL	03-3815-5411
Homepage URL
Email	nnakagawautmedsle@yahoo.co.jp

Sponsor
Institute	University of Tokyo
Institute
Department

Funding Source
Organization	not aplicable
Organization
Division
Category of Funding Organization	Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	University of Tokyo Hospital
Address	7-3-1 Hongo, Bunkyo-ward, Tokyo, Japan
Tel	0338155411
Email	nnakagawautmedsle@yahoo.co.jp

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2021 Year 09 Month 25 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Completed
Date of protocol fixation	2021 Year 09 Month 24 Day
Date of IRB	2021 Year 09 Month 25 Day
Anticipated trial start date	2021 Year 09 Month 25 Day
Last follow-up date	2021 Year 09 Month 25 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded	2022 Year 04 Month 20 Day

Other
Other related information	meta-analysis

Management information
Registered date	2021 Year 09 Month 24 Day
Last modified on	2022 Year 04 Month 25 Day

Link to view the page
URL(English)	https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000052012